PPI after MI linked to increased risk for adverse CV outcomes

Proton pump inhibitors (PPIs) are associated with an increased risk for adverse cardiovascular outcomes independent of clopidogrel use in patients who have had a myocardial infarction (MI), according to a new study published in the the Annals of Internal Medicine. In the study, the event rates were highest among patients who received a PPI (26.3%).

Bonnie - In addition to the following, I have heard several clients tell me that their gastroenterologists are beginning to find polyps in the stomach lining of their patients due to long-term PPI use.